Protein S is protective in pulmonary fibrosis

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Biochemistry

Background:

• Idiopathic pulmonary fibrosis (IPF) is a progressive, incurable lung disease characterized by excessive extracellular matrix deposition.
• Epithelial cell apoptosis is a key event in the pathogenesis of pulmonary fibrosis.
• Protein S, a vitamin K-dependent plasma anticoagulant, possesses significant antiapoptotic properties.

Purpose of the Study:

• To investigate the clinical relevance and protective role of Protein S in pulmonary fibrosis.
• To evaluate the impact of Protein S on apoptosis of lung epithelial cells and bleomycin-induced pulmonary fibrosis.

Main Methods:

• Enzyme immunoassays were used to measure circulating Protein S levels in patients with pulmonary fibrosis and controls.
• Pulmonary fibrosis was induced in wild-type and Protein S-transgenic mice using bleomycin.
• Exogenous Protein S was administered to wild-type mice to assess its therapeutic potential.

Main Results:

• Patients with pulmonary fibrosis exhibited reduced circulating Protein S levels compared to healthy controls.
• Protein S overexpression and exogenous administration significantly attenuated bleomycin-induced pulmonary fibrosis markers, including inflammation, cytokine levels, and lung hydroxyproline content.
• Protein S inhibited apoptosis in alveolar epithelial cells in vitro and reduced caspase-3 activity in vivo.

Conclusions:

• Protein S demonstrates a significant protective role in pulmonary fibrosis.
• Reduced circulating Protein S levels in patients suggest its clinical relevance in the disease.
• Targeting Protein S may represent a novel therapeutic strategy for pulmonary fibrosis.